Arnulf Stenzl

1990–2025 年に発表

178
論文数
23,147
被引用数
85
h 指数
165
i10 指数

被引用数

Arnulf Stenzl の年別被引用数1991 年: 被引用 1 件1992 年: 被引用 3 件1994 年: 被引用 2 件1995 年: 被引用 5 件1996 年: 被引用 6 件1997 年: 被引用 12 件1998 年: 被引用 11 件1999 年: 被引用 8 件2000 年: 被引用 6 件2001 年: 被引用 24 件2002 年: 被引用 18 件2003 年: 被引用 22 件2004 年: 被引用 18 件2005 年: 被引用 26 件2006 年: 被引用 23 件2007 年: 被引用 33 件2008 年: 被引用 40 件2009 年: 被引用 78 件2010 年: 被引用 95 件2011 年: 被引用 116 件2012 年: 被引用 141 件2013 年: 被引用 179 件2014 年: 被引用 190 件2015 年: 被引用 156 件2016 年: 被引用 169 件2017 年: 被引用 191 件2018 年: 被引用 184 件2019 年: 被引用 624 件2020 年: 被引用 660 件2021 年: 被引用 702 件2022 年: 被引用 586 件2023 年: 被引用 529 件2024 年: 被引用 781 件2025 年: 被引用 375 件2026 年: 被引用 16 件1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,942 件、この内訳の 19%中国: 引用元論文 965 件、この内訳の 9.4%ドイツ: 引用元論文 843 件、この内訳の 8.2%イギリス: 引用元論文 651 件、この内訳の 6.4%イタリア: 引用元論文 639 件、この内訳の 6.2%フランス: 引用元論文 448 件、この内訳の 4.4%オランダ: 引用元論文 423 件、この内訳の 4.1%カナダ: 引用元論文 414 件、この内訳の 4.1%スペイン: 引用元論文 332 件、この内訳の 3.2%日本: 引用元論文 317 件、この内訳の 3.1%スイス: 引用元論文 300 件、この内訳の 2.9%オーストリア: 引用元論文 263 件、この内訳の 2.6%
0%19%その他 26.4%

分野

  • Medicine70.1%
  • Biochemistry, Genetics and Molecular Biology16.4%
  • Immunology and Microbiology8%
  • Engineering2.4%
  • Computer Science0.8%
  • Psychology0.6%
  • その他1.7%

トピック

  • Bladder and Urothelial Cancer Treatments9.6%
  • Prostate Cancer Treatment and Research7.1%
  • Prostate Cancer Diagnosis and Treatment6%
  • Urinary and Genital Oncology Studies5%
  • Immunotherapy and Immune Responses3.7%
  • Cancer Immunotherapy and Biomarkers3.4%
  • その他65.2%

共著者

全論文

検索で開く
  1. ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 1,186

  2. Current best practice for bladder cancer: a narrative review of diagnostics and treatments

    著者: , , , , , , , , - The Lancet 2022 被引用: 434

  3. Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 299

  4. Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 277

  5. Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

    著者: , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2015 被引用: 284

  6. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions

    著者: , , , - Urologic Oncology Seminars and Original Investigations 2020 被引用: 215

  7. The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

    著者: , , , , , , - European Urology 2014 被引用: 571

  8. Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Celestia S. Higano, Matti Aapro, Michael Krainer, Stephan Hruby, Johannes Meran, S. Polyakov, Jean‐Pascal Machiels, Thierry Roumeguère, Koen Ackaert, Nicolaas Lumen, Thierry Gil, Velko Minchev, Antoaneta Tomova, Borislav D. Dimitrov, Marchela Koleva, Antonio Juretić, Ana Fröbe, Željko Vojnović, Martin Drabek, L. Jarolím, Tomáš Büchler, Eva Kindlová, Jan Schraml, Milada Zemanová, Prausova Jana, Bohuslav Melichar, Martina Chodacká, Jan Jansa, Gedske Daugaard, Nicolas Delonchamps, Brigitte Duclos, Stéphane Culine, G. Deplanque, Sylvestre Le Moulec, Peter Hammerer, Gerald Rodemer, Manuel Ritter, Axel S. Merseburger, Marc‐Oliver Grimm, Ilija Damjanoski, Manfred Wirth, Martin Burmester, Kurt Miller, Jan Herden, Bastian Keck, Christian Wuelfing, Alexander Winter, Martin Boegemann, Ingo Kausch von Schmeling, Paolo Fornara, E. Jaeger, G. Bodoky, Zsuzsanna Pápai, Géza Böszörményi-Nagy, Paola Vanella, Héctor Soto Parrà, Rodolfo Passalacqua, Francesco Ferraù, Michele Maio, Lucia Fratino, Enrico Cortesi, Gunta Purkalne, Jolita Asadauskienė, Rasa Jančiauskienė, Skaistė Tulytė, Alvydas Česas, Marco B. Polée, Brigitte C.M. Haberkorn, Fons van de Eertwegh, Pieter van den Berg ほか 83 名 - JAMA Oncology 2022 被引用: 90

  9. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

    著者: , , , , , , , - European Urology 2021 被引用: 220

  10. Prevention and early detection of prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 被引用: 492

  11. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kosei Hirakawa, Hiroaki Tanaka, Stefan Stevanović, Jürgen Frisch, Andrea Mayer-Mokler, Alexandra Kirner, Hans-Georg Rammensee, Carsten Reinhardt, Harpreet Singh‐Jasuja - Nature Medicine 2012 被引用: 784

  12. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial

    著者: , , , , , , , , , , , , , , , , , , , - European Urology 2018 被引用: 337

  13. Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 247

  14. Economic aspects of bladder cancer: what are the benefits and costs?

    著者: , , , , , , , , - World Journal of Urology 2009 被引用: 492

  15. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer

    著者: , , , , , , , - Urologic Oncology Seminars and Original Investigations 2017 被引用: 184

  16. Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer

    著者: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 164

  17. mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer

    著者: , , , - Human Vaccines & Immunotherapeutics 2014 被引用: 114

  18. IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 216

  19. TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 被引用: 46

  20. Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 387

  21. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

    著者: , , , , , , , , , - European Urology 2015 被引用: 278

  22. Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

    著者: , , , , , , , , , , , , , , - Molecular Therapy 2010 被引用: 219

  23. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Urology Oncology 2022 被引用: 40

  24. Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data

    著者: , , , , , , , , , , , , , - European Urology 2013 被引用: 450